Integrated palliative care for patients referred for Chimeric Antigen Receptor T-cell (CAR-T) therapy: A service evaluation

被引：0
|
作者：
Williams, R. [1 ]
Droney, J. M. [1 ]
Nicholson, E. [2 ]
Arias, C. [2 ]
Ellard, R. [2 ]
Bradley, N. [2 ]
Maycock, C. [2 ]
Halley, A. [1 ]
机构：
[1] Royal Marsden Hosp Chelsea, Symptom Control & Palliat Care Dept, London, England
[2] Royal Marsden Hosp Sutton, Haematol, Sutton, Surrey, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.811
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1614P
引用
收藏
页码：S892 / S893
页数：2
相关论文
共 50 条
  • [21] The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape
    Liyang Lyu
    Ye Feng
    Xin Chen
    Yuanjia Hu
    Nature Biotechnology, 2020, 38 : 1387 - 1394
  • [22] Upsetting the apple CAR-T (chimeric antigen receptor T-cell therapy) - sustainability mandates USA innovation
    Pantin, Jeremy
    Battiwalla, Minoo
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) : 851 - 853
  • [23] Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
    Brammer, Jonathan E.
    Braunstein, Zachary
    Katapadi, Aashish
    Porter, Kyle
    Biersmith, Michael
    Guha, Avirup
    Vasu, Sumithira
    Yildiz, Vedat O.
    Smith, Sakima A.
    Buck, Benjamin
    Haddad, Devin
    Gumina, Richard
    William, Basem M.
    Penza, Sam
    Saad, Ayman
    Denlinger, Nathan
    Vallakati, Ajay
    Baliga, Ragavendra
    Benza, Raymond
    Binkley, Philip
    Wei, Lai
    Mocarski, Mason
    Devine, Steven M.
    Jaglowski, Samantha
    Addison, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
  • [24] Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment
    Nenna, Antonio
    Carpenito, Myriam
    Chello, Camilla
    Nappi, Pierluigi
    Annibali, Ombretta
    Vincenzi, Bruno
    Grigioni, Francesco
    Chello, Massimo
    Nappi, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [25] Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
    Yan, Lingli
    Liu, Bainan
    ONCOTARGETS AND THERAPY, 2019, 12 : 193 - 204
  • [26] Cardiovascular Toxicities After Chimeric Antigen Receptor T-cell (CAR-T) Therapy: A Single Center Experience
    Dalal, Prarthana
    Patel, Nikita
    Cascino, Gregory
    Sinha, Arjun
    Sunderraj, Ashwin
    Feinstein, Matthew J.
    Akhter, Nausheen
    CIRCULATION, 2021, 144
  • [27] Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China's responses to address secondary cancer risks of CAR-T therapy
    Tan, Ruirong
    Li, Rui
    Dai, Meng-Yuan
    Liu, Miao
    Zhao, Junning
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [28] Fitness criteria for Australian patients referred for chimeric antigen receptor T-cell therapy
    Tam, Constantine S.
    Ho, P. J.
    Purtill, Duncan
    Blyth, Emily
    Butler, Jason
    Dickinson, Michael
    Harrison, Simon
    INTERNAL MEDICINE JOURNAL, 2022, 52 (08) : 1454 - 1456
  • [29] Psychosocial care for children receiving chimeric antigen receptor (CAR) T-cell therapy
    Steineck, Angela
    Wiener, Lori
    Mack, Jennifer W.
    Shah, Nirali N.
    Summers, Corinne
    Rosenberg, Abby R.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [30] EEG Findings in Chimeric Antigen Receptor T-Cell (CAR-T) Related Encephalopathy Syndrome
    Satyanarayan, Sammita
    Markert, Matthew
    Hovsepian, Dominic
    Post, David
    Muffly, Lori
    Miklos, David
    Thomas, Reena
    Scott, Brian
    NEUROLOGY, 2019, 92 (15)
12345